Manchanda, R;
Menon, U;
(2016)
Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial.
[Editorial comment].
BJOG: An International Journal of Obstetrics & Gynaecology
, 123
(3)
p. 463.
10.1111/1471-0528.13741.
Preview |
Text
Manchanda_Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial_AAM.pdf - Accepted Version Download (111kB) | Preview |
Abstract
Increasing evidence and acceptance of the role of the tube in the etiopathogenesis of ovarian cancer has led to opportunistic bilateral salpingectomy (OBS) being considered as an ovarian cancer prevention strategy for premenopausal women (who have completed childbearing) undergoing tubal sterilisation/benign gynaecological surgery. Some clinicians or jurisdictions (e.g. British Columbia) have incorporated this into routine practice. Recent guidelines from the American College of Obstetrics & Gynaecology and the Society of Gynaecological Oncology recommend that OBS be considered for ovarian cancer prevention, but also highlight the need/importance for further trials to confirm the validity and benefit of this approach.
Type: | Article |
---|---|
Title: | Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1111/1471-0528.13741 |
Publisher version: | https://doi.org/10.1111/1471-0528.13741 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10059211 |
Archive Staff Only
View Item |